news roundup
OmniComm Systems has entered into a merger agreement to become a wholly-owned subsidiary of Anju Software, a provider of data and application software to life sciences companies, contract research organizations, and medical device manufacturers.
Highlights from Elligo Health Research, Antidote, SCRS, QPS, PPD and more.
Optimal Just-in-Time, a service of PPD's Accelerated Enrollment Solutions (AES) business unit, and Cancer Treatment Centers of America (CTCA) are collaborating to bring under-represented cancer populations into clinical trials. The JIT service addresses community sites for faster site acitivation and patient recruitment.
Blog Posts
Washington correspondent Jill Wechsler discusses the current concerns around fast-track reviews against the backdrop of patient advocate concerns that reviews can delay access to potentially life-saving remedies. A main point of agreement between many parties is that products approved based on preliminary evidence should be priced much lower than the usual steep launch prices, until further research can document long-term efficacy and safety.
In this Q&A, Mo Heidaran, Vice President Technical, Regulatory and Technical CMC Consulting Cell, Gene Therapy and Tissue Engineering at Parexel, discusses
unforeseen challenges with gene and cell therapy clinical trial execution including supply chain, therapy preparation, and administration.
|
|
